Expert Speaker Faculty - LBx for Precision Oncology Summit

2025 Expert Speaker Faculty

Discover which expert speakers and KOLs presented at the 9th Liquid Biopsy for Precision Oncology Summit.

Amar Das

Vice President

Real World Evidence

Anneleen Daemen

Executive Director - Translational Medicine & Head Of Bioinformatics

ORIC Pharmaceuticals

Brian Haynes

Chief Scientific Officer & Head of Bioinformatics & Molecular Diagnostics Division

Bio-Techne Corporation

Carolina Reduzzi

Assistant Professor of Cancer Biology Research in Medicine

Weill Cornell Imaging

Chris Conn

Director, Clinical Biomarkers & Diagnostics, Global Diagnostics Strategy Lead

Amgen

Cynthia Sandoval, PhD

Senior Director, Clinical Biomarker Development

Eli Lilly

David Spetzler

President

Caris Life Sciences

David Tsao

Co-Founder & Chief Technology Officer

BillionToOne

David Weingeist

Director - Scientific & Oncology Diagnostics Leader

Johnson & Johnson Innovative Medicine

David Westenberg

Sr. Research Analyst

Piper Sandler

Deepa Parthasarathy

Director, Biomarker Operations

Repare Therapeutics

Ekaterina Gracheva

Epigenomics Application Specialist

Hologic Diagenode

Emily Finnegan

Director, Global Regulatory Affairs, Precision Medicine Digital Health

GSK

Erik Goka

Vice President - Biology & Precision Medicine

Revere Pharmaceuticals

Erin Newburn

Senior Director - Field Applications Scientist

LabCorp

Ezra Cohen

Chief Medical Officer - Oncology

Tempus

Fernando Cruz-Guilloty

Director

Johnson & Johnson

Frédéric Wuilque

Product Life Cycle Manager - Oncology

Volition

Gary Pestano

CDO

Biodesix

Greg Opiteck

Head, Precision & Translational Medicine

Affini-T Therapeutics

Gregory J Opiteck

Head, Precision & Translational Medicine

Affini-T Therapeutics

Holger Neecke

CEO

Tethis SpA

Hugh Wang

Director, Bioinformatics

Summit Therapeutics

Jane Antony

Manager, Companion Diagnostics

Abbvie

Janet Jin

Executive Director - Precision Medicine, Diagnostics & Imaging

Amgen

Jean-Francois Martini

Executive Director - Global Product Development, Oncology & Translational Oncology Lead

Pfizer

Jeff Gregg

Vice President Medical Affairs, Biofidelity - Professor of Pathology & Laboratory Medicine

University of Nevada School of Medicine

Joe McDermott

Bioinformatics Lead

Lantern Pharma

John Simmons

Global Vice President Biopharma

Natera

Jonathan Baden

Executive Director

Bristol Myers Squibb

Dr. Julia Elvin

Julia Elvin

Senior Vice President, Head of Precision Oncology

Foundation Medicine

Kate Cunningham

Applications Scientist

Personalis

Lauren Houghtalin

Director, Technical Sales, Disease State

BioIVT

Lauren Leiman

Executive Director

BLOODPAC

Lisa Boersma

Associate Director Precision Medicine

Regeneron

Marielena Mata

Senior Director - Clinical Biomarkers

Vividion Therapeutics

Matthew Pink

Vice President - Business Development

Biodesix (Moderator)

Paul Hofman, MD, PhD

Professor of Pathology

University Côte d'Azur

Paul Krzyzanowski

Medical Director

Johnson & Johnson Innovative Medicine

Peter Krein

Senior Vice President, Precision Medicine

Boundless Bio

Peter Teriete

Senior Director & Head of Lead Discovery

IDEAYA Biosciences

Prithwish Pal

Director - Global Product Marketing & Oncology

Bio-Rad

Qian Shi

Professor of Biostatistics and Oncology

Mayo Clinic

Rajiv Raja

Executive Director - Precision Medicine Oncology

GlaxoSmithKline

Robert Feeney

Director Account Solutions, Personalized & Precision Medicine

Novartis

Ryan Mathis

Vice President of Market Access & Business Development

Oxford Biodynamics

Sarah Shagan

Clinical Biomarker Lead

Genentech

Stephen Huang

Executive Director Clinical Biomarkers and CDx

Avenzo Therapeutics

Valerie Mbella

Director - Global Regulatory Affairs

Johnson & Johnson Innovative Medicine

“I'm thrilled to attend this liquid biopsy meeting, where the potential to transform cancer patient care and advance our field is truly within reach. This gathering offers an invaluable opportunity to explore the latest innovations, connect with leaders dedicated to pioneering solutions, and pave the way for more precise, personalized approaches to cancer treatment that could change countless lives”

Anneleen Daemen, Executive Director – Translational Medicine, ORIC Pharmaceuticals

2025 EVENT GUIDE

REGISTER INTEREST